79229680 - MERXIN

Information

• Trademark
• 79229680

• Source

• Serial Number

  79229680

• Registration Number

  5730393

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 18, 2018
  6 years ago

• Registration Date

  April 23, 2019
  5 years ago

• Transaction Date

  June 16, 2024
  5 months ago

• Status Date

  April 23, 2019
  5 years ago

• Published for Opposition Date

  February 05, 2019
  5 years ago

• Location Date

  August 23, 2023
  a year ago

• Status Code

  700

• Current Location

  TMEG LAW OFFICE 107

  Employee Name

  COLLOPY, DIANE PATRICI

• Attorney Docket Number

  00151/0004

  Attorney Name

  Anthony F. Lo Cicero

  Law Office Assigned Location Code

  L70

• Owners

  • Merxin Ltd

Case File Statements

• GS0091: [ Vials for scientific purposes being laboratory equipment; Vials for laboratory use; Glass tubes for scientific purposes being laboratory equipment ] * Laboratory equipment for scientific purposes, namely, vials *
• A00001: In the statement, lines 35-44 is deleted, medical inhalers that are sold empty and in bulk via business-to-business transactions through business-to-business channels of trade, is inserted. Page 2 lines 1-9 is deleted, design and development of medical inhalers sold empty and in bulk to third-party drug manufacturers and not for sale directly to end users, is inserted.
• GS0051: [ Pharmaceuticals for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for inhalers, namely, medical pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders structured for delivery into the body by nebulizer, aerosol, or dry powder, via the lungs or via the nasal passageway; Dietary supplements; Pharmaceutical products for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders ]
• GS0441: [ Pharmaceutical compounding services; Pharmaceutical compounding consultation services; Pharmaceutical compounding advisory services; Medical services; Veterinary services; Hygienic and beauty care for animals; Hygienic and beauty care for humans ]
• GS0101: * medical inhalers that are sold empty and in bulk via business-to-business transactions through business-to-business channels of trade * [ [ Surgical, medical, dental and veterinary apparatus and instruments, namely, injection devices for administering drugs sold empty; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical syringes sold empty for administering pharmaceuticals; Medical apparatus for introducing pharmaceutical preparations into the human body; Inhalers for medical use; ] Medical inhalers * Sold Empty * [ ; Respiratory monitors for medical use; Apparatus for measuring lung function; Spirometers for examining the function of the lungs; Spirometers; Spirometer mouth pieces and tubing; breath gas analyzers for medical diagnostics; Replacement cartridges for medical inhalers sold empty; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma and respiratory diseases ] ]
• GS0421: * design and development of medical inhalers sold empty and in bulk to third-party drug manufacturers and not for sale directly to end users * [ Scientific and technological services, namely, research and design in the field of drug delivery via the lungs or via the nasal passageway; Scientific and technological design of new products for others; Advisory services relating to [ design engineering ] * design of new products for others * ; Advisory services relating to [ product testing ] * testing of new products for others * ; Product design and development in the field of drug delivery via the lungs or via the nasal passageway; New product design services, namely, analysis and evaluation of product design; [ engineering design and consultancy ] * new product design and consultancy services * ; Professional consultancy relating to medical technology; [ engineering project management services, not for business purposes; Engineering research ] * project management services in the field of medical and pharmaceutical engineering, not for business purposes; Scientific research in the field of medical and pharmaceutical engineering * ; Pharmaceutical research and development services; research and development for the pharmaceutical industry; Research relating to medicines ]

Case File Event Statements

• 4/27/2018 - 6 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/5/2018 - 6 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 4/6/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/10/2018 - 6 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/28/2018 - 6 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/29/2018 - 6 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 5/3/2018 - 6 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW Type: RFWR

• 5/23/2018 - 6 years ago

  8 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/24/2018 - 6 years ago

  9 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/1/2018 - 6 years ago

  10 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/1/2018 - 6 years ago

  11 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 6/23/2018 - 6 years ago

  12 - REFUSAL PROCESSED BY IB Type: RFNT

• 6/29/2018 - 6 years ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/29/2018 - 6 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/29/2018 - 6 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/24/2018 - 6 years ago

  16 - FINAL REFUSAL WRITTEN Type: CNFR

• 7/24/2018 - 6 years ago

  17 - FINAL REFUSAL E-MAILED Type: GNFR

• 7/24/2018 - 6 years ago

  18 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 11/26/2018 - 6 years ago

  19 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 11/26/2018 - 6 years ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/27/2018 - 6 years ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/10/2018 - 5 years ago

  22 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/10/2018 - 5 years ago

  23 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/10/2018 - 5 years ago

  24 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/28/2018 - 5 years ago

  27 - ASSIGNED TO LIE Type: ALIE

• 12/10/2018 - 5 years ago

  25 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/10/2018 - 5 years ago

  26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/16/2019 - 5 years ago

  28 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/16/2019 - 5 years ago

  29 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/16/2019 - 5 years ago

  30 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 2/2/2019 - 5 years ago

  31 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 2/5/2019 - 5 years ago

  32 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/5/2019 - 5 years ago

  33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/23/2019 - 5 years ago

  34 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/14/2019 - 5 years ago

  35 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 7/23/2019 - 5 years ago

  36 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/14/2019 - 5 years ago

  37 - FINAL DISPOSITION PROCESSED Type: FIMP

• 8/14/2019 - 5 years ago

  38 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 8/30/2019 - 5 years ago

  39 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/18/2021 - 3 years ago

  40 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 5/18/2021 - 3 years ago

  41 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 5/18/2021 - 3 years ago

  42 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 5/18/2021 - 3 years ago

  43 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 5/18/2021 - 3 years ago

  44 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 5/18/2021 - 3 years ago

  45 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 5/18/2021 - 3 years ago

  46 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 5/18/2021 - 3 years ago

  53 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 5/18/2021 - 3 years ago

  47 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 5/18/2021 - 3 years ago

  48 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 5/18/2021 - 3 years ago

  49 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 5/18/2021 - 3 years ago

  50 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 5/18/2021 - 3 years ago

  51 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 5/18/2021 - 3 years ago

  52 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 10/14/2021 - 3 years ago

  54 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 10/18/2021 - 3 years ago

  55 - POST REGISTRATION ACTION MAILED - SEC. 7 Type: PRAM

• 10/22/2021 - 3 years ago

  56 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 10/26/2021 - 3 years ago

  57 - CANCELLED SEC. 7 - PARTIAL Type: C7P.

• 10/26/2021 - 3 years ago

  58 - POST REGISTRATION ACTION CORRECTION Type: XXXX

• 10/27/2021 - 3 years ago

  59 - NOTICE OF PARTIAL CANCELLATION SEC. 7 SURRENDER EMAILED Type: NCP7

• 11/24/2021 - 3 years ago

  60 - OTQR WITHDRAWAL FROM PUBLICATION Type: WDRL

• 1/3/2022 - 2 years ago

  61 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 1/3/2022 - 2 years ago

  62 - POST REGISTRATION ACTION MAILED - SEC. 7 Type: PRAM

• 1/4/2022 - 2 years ago

  63 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP

• 1/5/2022 - 2 years ago

  64 - AMENDMENT UNDER SECTION 7 - PROCESSED Type: A7OK

• 8/23/2022 - 2 years ago

  66 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA

• 7/9/2022 - 2 years ago

  65 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR

• 2/15/2023 - a year ago

  67 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 3/6/2023 - a year ago

  68 - ASSIGNED TO PARALEGAL Type: PLGL

• 3/7/2023 - a year ago

  69 - AMENDMENT UNDER SECTION 7 - PROCESSED Type: A7OK

• 4/11/2023 - a year ago

  70 - NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED Type: NURC

• 5/15/2023 - a year ago

  71 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 8/22/2023 - a year ago

  72 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 8/23/2023 - a year ago

  73 - CANCELLED SEC. 7 - PARTIAL Type: C7P.

• 8/23/2023 - a year ago

  74 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 8/24/2023 - a year ago

  75 - NOTICE OF PARTIAL CANCELLATION SEC. 7 SURRENDER EMAILED Type: NCP7

• 4/23/2024 - 7 months ago

  76 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 4/23/2024 - 7 months ago

  77 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR

• 6/16/2024 - 5 months ago

  79 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 5/2/2024 - 6 months ago

  78 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA